GPC1 and neoplasm: Our observation of the paradoxical behaviors in prostate tumor growth between in vitro and in vivo models led us to hypothesize that inhibition of GPC-1 expression in prostate cancer cells remodeled the TME and subsequently affected tumor growth by mediating cancer-stromal cell interactions.